Both in Pharmaceuticals

Verrica Pharmaceuticals vs Rein Therapeutics

Over the past year VRCA returned −7.6% and RNTX returned −61.9%; their daily moves had a correlation of 0.13.

VRCA −7.6% RNTX −61.9%Growth of $1, one year, split-adjusted
MetricVRCARNTX
Price$3.29$0.6675
Market cap$56.5M$57.6M
Today+2.49%+5.05%
1 month−23.7%−19.1%
6 months−54.1%−34.6%
Year to date−60.4%−42.5%
1 year−8.9%−57.3%
Revenue growth (YoY)−53.8%—
Gross margin85.0%—
Net margin−224.4%—
P/E (TTM)——
Price / sales1.9×—
Net cash$9.8M$40.6M
Dividend yield——
Volatility (60d)62.8%96.0%
Short % of float2.5%2.6%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).